Current treatments from Israel’s Teva include Austedo (involuntary movements), Ajovy (migraine), and Uzedy (schizophrenia). It expects soon to launch Olanzapine (schizophrenia), Duvakitug (IBD), Dari (asthma), Emrusolmin (Multiple System Atrophy), and has fast-tracked TEV-53408 (Celiac).
https://en.globes.co.il/en/article-teva-gives-aggressive-guidance-on-1001511802